PubRank

S R Lakhani

Author PubWeight™ 64.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005 6.18
2 Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000 3.42
3 Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995 2.91
4 Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet 1998 2.70
5 Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 2006 2.40
6 Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006 1.98
7 Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer. Br J Cancer 2004 1.87
8 Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006 1.80
9 Comparative genomic hybridization reveals extensive variation among different MCF-7 cell stocks. Cancer Genet Cytogenet 2000 1.65
10 CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001 1.62
11 EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol 2006 1.57
12 Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 1995 1.57
13 Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol 2003 1.55
14 Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer 2006 1.48
15 Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes. Oncogene 2010 1.45
16 Differences among Asian patients. Br Med J (Clin Res Ed) 1986 1.34
17 Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998 1.33
18 Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 1995 1.33
19 Demystifying basal-like breast carcinomas. J Clin Pathol 2007 1.22
20 The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene 1996 1.19
21 Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 2008 1.13
22 Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol 2000 1.09
23 Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer 2000 1.07
24 Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab Invest 2000 1.06
25 Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma. Br J Cancer 2006 1.05
26 High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer 1999 1.03
27 Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Int J Cancer 1998 1.02
28 Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women. Breast Cancer Res Treat 2013 0.98
29 Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 2001 0.96
30 Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000 0.96
31 Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13. Hum Genet 2000 0.95
32 Breast cancer special types: why bother? J Pathol 2008 0.94
33 Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Histopathology 1999 0.93
34 Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. Br J Cancer 2006 0.92
35 Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 2001 0.90
36 Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast. J Clin Pathol 2004 0.87
37 Proliferation and differentiation in the human breast during pregnancy. Differentiation 2000 0.86
38 The pathology of familial breast cancer: Immunohistochemistry and molecular analysis. Breast Cancer Res 1999 0.85
39 Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit. Oncogene 2010 0.85
40 Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis 2014 0.84
41 Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast. Br J Cancer 2004 0.80
42 Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett 2001 0.79
43 neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast. Hum Pathol 1995 0.79
44 Profiling familial breast cancer. Nat Med 2001 0.78
45 How diagnosis with microarrays can help cancer patients. Nature 2000 0.78
46 Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. Br J Cancer 1998 0.76
47 Collagenous spherulosis in an adenomyoepithelioma of the breast. J Clin Pathol 2004 0.75
48 Terminology for carcinoma-in-situ of the breast. Lancet 1996 0.75
49 DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer. Oncogene 2017 0.75
50 MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change. Eur Radiol 2001 0.75
51 The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction. Br J Plast Surg 2004 0.75
52 Morphological and molecular analysis of a breast cancer cluster at the ABC Studio in Toowong. Pathology 2012 0.75